Lastet and bone sarcoma Patient Reports February 13, 2012

Lastet Side Effects Report #5044411-2
Lastet side effect was reported by a Health Professional from JAPAN on May 31, 2006. Male patient, child 5 years of age, was diagnosed with retinoblastoma bilateral and was treated with Lastet. After drug was administered, patient experienced the following side effects: bone marrow failure, bone sarcoma, dyspnoea, treatment related secondary malignancy. Lastet dosage: unknown. During the same period patient was treated with PARAPLATIN, CYCLOPHOSPHAMIDE, IFOSFAMIDE, PIRARUBICIN, MELPHALAN, MABLIN, THIOTEPA. Patient died on 08/01/2004.

Lastet Side Effects Report #5044404-5
Lastet side effect was reported by a Consumer or non-health professional from UNITED STATES on June 21, 2006. Male patient, child 5 years of age, was diagnosed with retinoblastoma and was treated with Lastet. After drug was administered, patient experienced the following side effects: bone sarcoma. Lastet dosage: unknown. During the same period patient was treated with ENDOXAN, CARBOPLATIN, IFOSFAMIDE, THERARUBICIN, ALKERAN, MABLIN, THIOTEPA. Patient died on 08/01/2005.

Lastet Side Effects Report #5039473-2
Lastet side effect was reported by a Consumer or non-health professional from UNITED STATES on June 21, 2006. Male patient, child 5 years of age, was diagnosed with retinoblastoma and was treated with Lastet. After drug was administered, patient experienced the following side effects: bone sarcoma. Lastet dosage: unknown. During the same period patient was treated with ENDOXAN, CARBOPLATIN, IFOSFAMIDE, THERARUBICIN, ALKERAN, MABLIN, THIOTEPA. Patient died on 08/01/2005.